The market for CBD-infused beverages is expected to exceed $14 billion by the end of 2026, according to a new report by Grand View Research, Inc. The market is growing due to the growing number of consumers who are seeking alternatives to treating ailments and pain associated with chronic pain conditions, such as arthritis, depression and insomnia.

Cannabidiol (CBD) is a non-intoxicating compound found in the marijuana plant, with a wide range of medicinal potentials. Its use in dietary supplements has been in the media for years and the market has been growing in popularity and demand, although there is still a lot of uncertainties about its use and consumption.

CBD is the second most common active ingredient in marijuana. CBD is extracted directly from the cannabis plant, a relative of the marijuana plant and a key ingredient of medical marijuana. Although CBD is a component of marijuana, it has no hallucinogenic effect on the human mind. According to a World Health Organization report, CBD does not cause effects in humans that indicate potential abuse or dependence. So far, there is no evidence that the use of pure CBD and its derivatives is associated with health problems. CBD particles are put into water to make CBD-soaked drinks. The end product is a preserved beverage, usually carbonated, that tastes like flavored sparkling water or seltzer with fizz. CBD drinks are becoming increasingly popular as cannabis-infused products, such as medical and recreational marijuana, are legalized in the United States and around the world. The appeal of CBD has been fueled by its increasing availability combined with a growing health trend where more and more people are opting for healthier alternatives to sugary drinks. Different types of CBD drinks are a great alternative with health benefits because CBD drinks come from a natural source. The following companies are active in the market this week: Grove, Inc. (NASDAQ: GRVI), Pressure BioSciences, Inc. (OTCQB: PBIO), Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY), NewAge, Inc. (NASDAQ: NBEV), Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED).

The Facts & Factors report forecasts that the global CBD-infused beverages market, valued at around US$3,400 million in 2020, will reach over US$14,600 million by the end of 2026, growing at a CAGR of around 27.5% between 2021 and 2026. The report states: The market for CBD-infused beverages is largely driven by the increasing approval and certification of recreational cannabis in countries like the US and Canada. Moreover, due to the increasing incidence of many respiratory diseases, there is a growing trend of no longer smoking cannabis but switching to healthier edibles, which is driving the market growth. Moreover, the global industry is further boosted by the widespread availability of CBD drinks such as coffee, fruit punch, cola tea with cannabis and other CBD drinks in various legal marijuana outlets. Several key players in the CBD-enriched beverage industry have also chosen to invest in the development of new flavored beverages…. The increasing use of CBD drinks in cancer patients to treat nausea, weight loss, and loss of appetite is contributing to the growth of the market. Moreover, the growing popularity of this functional drink among athletes and sports enthusiasts has led to increased demand for the product in the sports nutrition industry. Numerous advances in cannabis microdosing have led to the creation of CBD-based alcohol-free beers, which should help expand the market …

Print BioSciences, Inc. (OTCQB: PBIO) LATEST NEWS: Pressure BioSciences’ UST-activated nanoemulsions exceed one-year stability target; Results reveal explosive growth potential for CBD-enriched water-soluble beverages worldwide – Pressure BioSciences, a leading developer and distributor of innovative, pressure-based tools, consumables and services for the global biotech, biotherapeutics cosmetics and nutraceuticals industries Pressure BioSciences today announced that processing cannabidiol (CBD) from hemp with its Ultra Shear Technology™ (UST™) platform produces water-soluble nanoemulsions of high-quality CBD oil in water with the distinct advantage of scientifically proven long-term stability.  Specifically, the company reported breakthrough results when its UST processing platform produced stable, ultra-fine nanodispersions of CBD oil in water, which were required to ensure product stability for 12 months under both refrigerated and ambient conditions, even with multiple freeze-thaw cycles, with no visible or measurable degradation of the nanoemulsified product.

CBD is a non-psychoactive, oil-soluble compound extracted from the cannabis plant and is usually sold as a vegetable oil solution. CBD is widely known for its many health benefits, from relief of stress and anxiety to schizophrenia, reduction of cramps, muscle pain, joint pain, cancer pain and more, and reduction of inflammation. Because CBD is oil-based, ingestion or local application generally results in low absorption in aquatic living systems such as humans. For example, the World Health Organization estimates that the bioavailability of CBD when administered orally to oil-based products is only 6%.  This means that most of the CBD ingested is lost as it passes through the body and is not absorbed. Therefore, there is considerable interest in developing a truly water-soluble CBD to achieve effective dosage, absorption and bioavailability in foods and beverages.

ProVerde Laboratories is one of the most advanced analytical laboratories in the country. It provides analytical services for cannabis-derived materials, including cannabinoid profiling and particle size determination. Dr. Christopher Hudalla, President and Chief Scientific Officer of ProVerde Labs, provided an important insight: We regularly test hundreds of cannabis products, and the overwhelming variety of so-called water-soluble products we test invariably suffer from poor particle uniformity and lack of long-term stability. This often leads to cannabinoid degradation, phase separation, coalescence and sludge formation. The introduction of a new technology platform capable of consistently producing the ultra-low droplet size nanoemulsions required for a reliable shelf life of over a year, including freeze and thaw resistance, will be a breakthrough and explosive growth opportunity in the CBD and cannabis products industry.

Mr. John Westlake, founder and president of Canopy CBD Farms, LLC. also confirmed: There is strong scientific evidence for the urgent need to process CBD hemp oil into water-soluble nanoemulsions to achieve maximum absorption and bioavailability with optimal dosage safety and overall product profitability for manufacturers and consumers.  For commercial success, these CBD nanoemulsions must also be stable over time, so the CBD product still has the best chance of delivering on its promise after several months of distribution and shelf storage. In my many years in the cannabis market, this is the first time I’ve seen such an achievement: a high-quality CBD oil-in-water nanoemulsion that is stable for a year at both low temperatures and room temperature, even after numerous freeze-thaw cycles.  These results are very impressive.

Dr. Gary B. Smekal, Senior Scientist at PBI, spoke about the company’s breakthrough: To ensure the long-term stability of nanoemulsions, production processes are required that guarantee a constant and extremely small size of the oil droplets in water. Our unique formulations and patented UST technology platform use unprecedented high pressure to achieve repeated cycles of extreme shear at controlled temperatures and flow rates, which we believe provides the best quality and long-term stability for CBD nanoemulsions available in the world today.

Mr John B. Hollister, Director of Sales and Marketing at PBI, said of the occasion: CBD-containing nanoemulsions produced using our innovative and patented UST technology platform have the potential to revolutionize the rapidly growing cannabis market, not only in the food and beverage industry, but also in many other areas such as biotherapeutics, nutraceuticals, agrochemicals and cosmetics.  Whether it’s really clear, water-soluble infusions in beverages with a long shelf life at cold or room temperature, or a predictable dosage with a much faster effect than other edible forms, we think the benefits and appeal to consumers will be enormous.  We are pleased to have reached this historic milestone and surpassed one year of real-time stability at low and ambient temperatures. We look forward to bringing our first UST-based nanoemulsion system to market by the end of 2021 or earlier. Read this full issue and other news from Pressure BioSciences at:

Other recent market developments include:

Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY), a global leader in cannabis and consumer products, recently announced that its SweetWater Brewing Company has entered into a partnership with leading Canadian brand Broken Coast Cannabis Ltd. which is part of the Tilray portfolio, is based in British Columbia and focuses on the premium cannabis market. Broken Coast BC Lager is the first inter-brand product developed in partnership with leading craft brands SweetWater and Broken Coast, and the first Canadian cannabis brand to be launched by Tilray in the US.

We’re here to build great brands that deliver products consumers love, and we hope to have fun along the way, said Irwin D. Simon, president and CEO of Tilray. This cross-partnership between SweetWater and Broken Coast is the first of many steps in our growth and execution strategy to bring our great Canadian cannabis brands to the U.S. and connect our consumers with other brands in our portfolio.

NewAge, Inc. (NASDAQ: NBEV), a Colorado-based organic and healthy food company striving to become a global leader in social selling and distribution, recently announced a manufacturing partnership and agreement to sell its U.S. manufacturing facilities to Taiwan-based TCI Co.

TCI, which is listed on the Taiwan Stock Exchange, was founded in 1980. Since then, annual sales have grown to nearly $300 million and the number of employees worldwide to more than 1,150. TCI is a leading manufacturer of functional beverages, skin care products, nutritional supplements and other health products, with manufacturing and biotechnology operations in Taiwan, the People’s Republic of China, Japan, the Netherlands and now the United States, and exports to more than 50 countries worldwide. TCI is also a leader in research and development, with an extensive portfolio of biologically diverse products, including more than 200 patents, and was recently named one of the fastest growing companies in Asia by the Financial Times.

Canopy Growth Corporation (NASDAQ: CGC) (TSX: WEED) and The Supreme Cannabis Company, Inc. (OTCQX: SPRWF) recently announced the completion of a previously announced agreement (the Agreement) pursuant to which Canopy acquired all of the issued and outstanding common shares of Supreme (the Supreme Shares).

While Canopy continues to focus on the premium floral segment, the acquisition of 7ACRES and 7ACRES Craft Collective strengthens Canopy’s market leadership position and complements its production capabilities with the acquisition of a low-cost, scalable Supreme facility in Kincardine, Ontario. The company has a proven track record of producing high quality flowers from sought after varieties, which has helped the Supreme brands gain a loyal following among consumers. In addition, the acquisition of Supreme strengthens Canopy’s leadership position in the Canadian recreational market and creates a notional market share in the fourth quarter of 2021 of 18.1%. Moreover, the acquisition offers the possibility of immediate value creation: Synergies of an estimated $30 million are expected to be realized over the next two years.

Grove, Inc. (NASDAQ: GRVI) recently entered the growing market for plant-based chewable vitamins with its newest product line, Qubes.  The brand is currently offering unique products to its customers: Apple cider vinegar + acai, turmeric for immunity, and the upcoming seaweed oil supplement that will serve as a plant-based alternative to fish oil for daily omega-3 consumption.

Qubes chews contain no preservatives, chemicals, corn syrup, allergens, soy, dairy, wheat, salicylates, artificial ingredients, artificial sweeteners, flavors or colors.  This new launch is designed to respond to the growing demand for vitamins. The global chewable vitamins market is estimated at USD 5.9 billion in 2020 and is expected to reach USD 10.6 billion by 2025, at a CAGR of 12.5%.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates and, is a third-party publisher and news distribution service provider that delivers electronic news through multiple online media channels. The FNM is not affiliated with any of the companies mentioned in this document. FNM and its affiliates are a provider of news dissemination solutions and are NOT registered brokers/dealers/analysts/advisers, have no investment licenses and may NOT sell, offer to sell or offer to buy any securities.  FNM’s market updates, press releases and company profiles do NOT constitute an offer or recommendation to buy, sell or hold securities. The contents of this communication are for information purposes only and should NEVER be construed as research material.  All readers are strongly advised to conduct their own research and seek advice from a licensed financial professional before considering an investment in equities.  All documents in this press release are reprints of documents and information previously distributed by the companies mentioned in this press release.  The FNM is not responsible for the investment decisions of its readers or subscribers.  Investors are warned that they could lose all or part of their investment when investing in shares. For services rendered, FNM received a fee of forty-six dollars for covering recent press releases from Pressure BioSciences, Inc.  FNM DOES NOT OWN ANY SHARES IN THE COMPANIES MENTIONED IN THIS ANNOUNCEMENT.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe future expectations, plans, outcomes, or strategies and are typically preceded by words such as possible, future, expected, projected, possible, or anticipated. We caution you that these statements are subject to numerous risks and uncertainties that could cause future conditions, events or results to differ materially from those anticipated in the forward-looking statements, including the risk that actual results will differ materially from those anticipated in the forward-looking statements as a result of various factors, as well as other risks described in the Company’s Annual Report on Form 10-K or 10-KSB and in other filings with the Securities and Exchange Commission. You should consider these factors when evaluating forward-looking statements in this document and should not place undue reliance on them. The forward-looking statements in this press release were made as of the date of this press release and FNM undertakes no obligation to update these statements.

cbd coffeerecess drink reviewis hemp and cbd the samecbd products amazon,People also search for,Privacy settings,How Search works,cbd coffee,recess drink review,is hemp and cbd the same,cbd products amazon

You May Also Like

Senate Parliamentarian May Have Foiled Schumer’s Marijuana Legalization Plan

At the time this post was published, the Senate’s Parliamentarian had not…

What does the new law mean for the state?

The new law is not legalisation of marijuana, rather it is a…

Cannabis Clubs in South Africa Remain in Legal Limbo

The South African government has made a decision that is unprecedented in…